|
|
| (11) | Number of the document | C 2805720 |
| (68) | Number of the document | 2805720 |
| (21) | Application number for Supplementary Protection Certificate | PA 2024 518 |
| (22) | Date of filing the application | 2024-06-13 |
| (41) | Date of publication of the application | 2024-07-10 |
| Date of publication of SPC | 2025-11-10 | |
| (24) | Date of coming into effect of SPC | 2029-05-29 |
| (71) |
ReveraGen BioPharma, Inc.,
155 Gibbs Street, Suite 433, Rockville, MD 20850,
US
|
| (73) |
ReveraGen BioPharma, Inc.,
155 Gibbs Street, Suite 433, Rockville, MD 20850,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/23/1776, 2023-12-14 |
| (94) | 2034-05-28 |
| (95) | Vamorolonas |
| SPC granted |